Ayurcann Holdings Corp. (AYURF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ayurcann Holdings Corp. (AYURF) trades at $0.00 with AI Score 51/100 (Grade B). Ayurcann Holdings Corp. is a Canadian company specializing in post-harvest outsourcing solutions for licensed cannabis producers. Market cap: $330,997, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for AYURF: AYURF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AYURF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
AYURF: the 1 perspectives are evenly split.
How is this calculated? →Ayurcann Holdings Corp. (AYURF) Healthcare & Pipeline Overview
Ayurcann Holdings Corp. provides integrated post-harvest solutions for cannabis producers in Canada, offering services from extraction to distribution, alongside a marketplace for medical cannabis, thereby establishing a strong foothold in the expanding cannabis sector.
What Is the Investment Thesis for AYURF?
Ayurcann Holdings Corp. is positioned to capitalize on the expanding Canadian cannabis market, driven by increasing consumer demand for both medicinal and recreational cannabis products. The company's gross margin of 33% indicates a solid operational framework, although it currently faces a profit margin of -14%. Key growth catalysts include the expansion of its Ayurcann marketplace and the continuous development of innovative products, which could enhance revenue streams. The Canadian cannabis market is projected to grow significantly, and Ayurcann's comprehensive service offerings provide a competitive edge. However, potential risks include regulatory changes and market competition that could impact profitability. Investors should monitor these dynamics closely as the company navigates its growth trajectory.
Based on FMP financials and quantitative analysis
AYURF Key Highlights
- Market Cap: $0.00B indicating a current valuation status.
- Gross Margin of 33.0%, reflecting the company's efficiency in managing production costs.
- Profit Margin of -14.0%, highlighting current operational challenges.
- Beta of 0.88, suggesting lower volatility compared to the broader market.
- No dividend yield, indicating a focus on reinvestment rather than returning capital to shareholders.
Who Are AYURF's Competitors?
AYURF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| APHA APHA | $15.27 | -1.04% | 56 | |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AYURF's Key Strengths?
- Diverse range of post-harvest services tailored for cannabis producers.
- Strong focus on compliance and quality assurance.
- Established marketplace for direct consumer sales.
What Are AYURF's Weaknesses?
- Current negative profit margin indicating operational challenges.
- Limited brand recognition compared to larger competitors.
- Dependence on the Canadian market, which may limit growth.
What Could Drive AYURF Stock Higher?
- Expansion of Ayurcann marketplace to enhance consumer reach and sales.
- Development of new product formulations to meet evolving consumer preferences.
- Strategic partnerships with licensed producers to increase service offerings.
What Are the Key Risks for AYURF?
- Financial-distress signal — its Altman Z-Score of -2.07 sits in the distress zone (elevated bankruptcy risk).
- Regulatory changes impacting operational capabilities and market access.
- Intense competition from larger, established cannabis companies.
- Market volatility affecting consumer spending and demand for products.
What Are the Growth Opportunities for AYURF?
- Expansion of Ayurcann Marketplace: The Ayurcann marketplace provides a unique platform for medical cannabis consumers, which is expected to grow significantly as more consumers seek online purchasing options. The Canadian e-commerce cannabis market is projected to reach CAD 1 billion by 2028, offering Ayurcann a substantial growth opportunity as it enhances its online presence and product offerings.
- Increasing Demand for Medicinal Cannabis: With a growing number of patients seeking alternative therapies, the demand for medicinal cannabis products such as tinctures and topicals is on the rise. The global medicinal cannabis market is projected to grow at a CAGR of 24% from 2021 to 2028, providing Ayurcann with a favorable environment to expand its product lines and capture market share.
- Partnerships with Licensed Producers: By forming strategic partnerships with licensed cannabis producers, Ayurcann can enhance its service offerings and expand its client base. Collaborations can lead to increased sales volumes and improved operational efficiencies, positioning the company for sustained growth in the competitive cannabis landscape.
- Development of Innovative Products: Ayurcann's focus on product innovation, including new formulations and delivery methods, can attract a broader customer base. As consumer preferences evolve, the company's ability to introduce unique and effective cannabis products will be crucial for maintaining its competitive edge.
- Regulatory Advancements: As regulations surrounding cannabis continue to evolve, Ayurcann is well-positioned to adapt and capitalize on new opportunities. Changes that facilitate easier access to cannabis products or expand the range of allowable products could drive growth for Ayurcann and its partners.
What Opportunities Does AYURF Have?
- Expansion of the online marketplace to capture growing e-commerce demand.
- Increased acceptance of medicinal cannabis driving product sales.
- Potential for strategic partnerships to enhance service offerings.
What Threats Does AYURF Face?
- Intense competition from established cannabis companies.
- Regulatory changes that could impact operations.
- Market volatility affecting consumer spending on cannabis products.
What Are AYURF's Competitive Advantages?
- Comprehensive service offerings that address multiple aspects of cannabis production.
- Established relationships with licensed producers enhancing customer loyalty.
- Expertise in compliance with Canadian cannabis regulations, reducing operational risks.
What Does AYURF Do?
Founded in 2018 and headquartered in Pickering, Canada, Ayurcann Holdings Corp. has emerged as a significant player in the cannabis industry by offering post-harvest outsourcing solutions to licensed cannabis producers. The company specializes in providing end-to-end services, including extraction and refinement processes, bulk distillate oil sales, formulation, and white label manufacturing. Ayurcann also offers fulfillment and distribution services, customized packaging solutions, and inventory management, catering to the diverse needs of cannabis producers. In addition to these services, Ayurcann provides medicinal cannabis products such as tinctures, vapes, and topicals, enhancing its product portfolio. The company operates the Ayurcann marketplace, an online platform designed for medical cannabis consumers, further diversifying its offerings and reaching a broader audience. Ayurcann's commitment to quality and compliance with Canadian regulations positions it competitively within the industry, as it strives to meet the growing demand for cannabis products and services in a rapidly evolving market.
What Products and Services Does AYURF Offer?
- Provide post-harvest outsourcing solutions to licensed cannabis producers.
- Offer extraction and refinement services for cannabis products.
- Sell bulk distillate oil and formulate white label products.
- Manage fulfillment and distribution logistics for cannabis producers.
- Deliver customized packaging solutions and inventory management services.
- Operate the Ayurcann marketplace for medical cannabis consumers.
How Does AYURF Make Money?
- Generate revenue through service fees for extraction, refinement, and distribution.
- Sell cannabis products directly to consumers via the Ayurcann marketplace.
- Offer white label manufacturing services to other cannabis brands.
- Provide inventory management and logistics services to licensed producers.
What Industry Does AYURF Operate In?
The cannabis industry in Canada has been experiencing rapid growth since legalization, with significant demand for both recreational and medicinal products. The market is expected to continue expanding, driven by increasing consumer acceptance and regulatory support. Ayurcann Holdings Corp. operates in a competitive landscape, facing challenges from established players and new entrants. The company's focus on post-harvest solutions positions it uniquely, as it provides essential services that support the production and distribution of cannabis products. As the market evolves, companies that can adapt to regulatory changes and consumer preferences will likely thrive.
Who Are AYURF's Key Customers?
- Licensed cannabis producers seeking post-harvest solutions.
- Medical cannabis consumers purchasing products through the Ayurcann marketplace.
- Businesses looking for white label manufacturing options.
Ayurcann Holdings Corp. (AYURF) Valuation Context
Valued at 331K, AYURF is classified as a micro-cap stock. Relative to its peer group, AYURF's quantitative score of 51/100 is below the peer average of 65/100.
AYURF Revenue & Earnings Trend
In Q3 2025, AYURF generated $6.1M in top-line revenue, marking a sequential decrease of 21.4%. The company recorded a net loss of $793K, with diluted EPS of $-0.00. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, AYURF averaged $-0.00 in diluted EPS.
Company Profile
Ayurcann Holdings Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Pickering, CA. The company is led by CEO Igal Sudman. AYURF has traded publicly since 2014.
ROE 244%Key Financial Metrics
Return on equity for Ayurcann Holdings Corp. stands at 244.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -38.5%, showing how much profit it generates from its asset base. Its free cash flow yield is 32.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.61 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 4/9Financial Health
Ayurcann Holdings Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.07 places it in the distress zone, a signal of elevated financial risk.
AYURF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diverse range of post-harvest services tailored for cannabis producers.
- Strong focus on compliance and quality assurance.
- Established marketplace for direct consumer sales.
- Upcoming: Expansion of Ayurcann marketplace to enhance consumer reach and sales.
Bear Case
- Current negative profit margin indicating operational challenges.
- Limited brand recognition compared to larger competitors.
- Dependence on the Canadian market, which may limit growth.
- Potential: Regulatory changes impacting operational capabilities and market access.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $6M | -$792,611 | -$0.0041 |
| Q2 2025 | $8M | -$2M | -$0.01 |
| Q1 2025 | $8M | -$561,770 | -$0.0029 |
| Q4 2024 | $8M | -$121,718 | -$0.0006 |
Based on FMP financials and quantitative analysis
AYURF Latest News
No recent news available for AYURF.
AYURF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AYURF.
Price Targets
Wall Street price target analysis for AYURF.
AYURF MoonshotScore
What does this score mean?
The MoonshotScore rates AYURF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Igal Sudman
CEO
Igal Sudman has extensive experience in the cannabis industry, having co-founded Ayurcann Holdings Corp. in 2018. With a background in business management and operations, he has played a pivotal role in shaping the company's strategic direction and growth. Prior to joining Ayurcann, Sudman held various leadership positions in the healthcare and cannabis sectors, contributing to his deep understanding of the market dynamics and regulatory landscape.
Track Record: Under Igal Sudman's leadership, Ayurcann has successfully established itself as a key player in the cannabis outsourcing space, expanding its service offerings and launching the Ayurcann marketplace. His strategic vision has driven the company's growth and positioned it well for future opportunities in the rapidly evolving cannabis industry.
AYURF OTC Market Information
The OTC Other tier includes companies that do not meet the financial requirements for higher tiers, such as the NYSE or NASDAQ. These companies may have less stringent reporting requirements, which can lead to varying levels of transparency and liquidity. Investors should be aware that trading on this tier may involve higher risks due to less oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosures compared to companies listed on major exchanges.
- Potential for higher volatility due to lower trading volumes.
- Increased risk of fraud or misrepresentation in less regulated markets.
- Review recent financial statements and operational updates.
- Examine the company's compliance with Canadian cannabis regulations.
- Assess the competitive landscape and market positioning.
- Investigate management's track record and strategic vision.
- Monitor industry trends and potential regulatory changes.
- Established partnerships with licensed cannabis producers.
- Transparency in operational practices and compliance efforts.
- Presence of experienced leadership with a solid industry background.
What Investors Ask About Ayurcann Holdings Corp. (AYURF) — Healthcare
What does Ayurcann Holdings Corp. do?
Ayurcann Holdings Corp. specializes in providing post-harvest outsourcing solutions for licensed cannabis producers in Canada. The company offers a comprehensive suite of services, including extraction, refinement, bulk distillate oil sales, and white label manufacturing. Additionally, Ayurcann operates an online marketplace for medical cannabis consumers, enhancing its product offerings and market reach.
What are the main risks for AYURF?
Ayurcann Holdings Corp. faces several risks, including regulatory changes that could impact its operations and market access. Additionally, the company operates in a highly competitive landscape, where larger, established cannabis companies pose a significant threat. Market volatility may also affect consumer spending on cannabis products, impacting overall demand and revenue.
How does Ayurcann Holdings Corp. navigate regulatory approval processes?
Ayurcann Holdings Corp. navigates regulatory approval processes by maintaining a strong focus on compliance with Canadian cannabis regulations. The company has established protocols to ensure that all products and services meet legal standards, which is crucial for operating within the cannabis industry. By staying informed about regulatory changes and proactively adapting its operations, Ayurcann aims to mitigate risks associated with compliance.
What are the key factors to evaluate for AYURF?
Ayurcann Holdings Corp. (AYURF) holds an AI score of 51/100 (moderate). Not financial advice.
How frequently does AYURF data refresh on this page?
AYURF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AYURF's recent stock price performance?
Ayurcann Holdings Corp. (AYURF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse range of post-harvest services tailored for cannabis producers. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AYURF overvalued or undervalued right now?
Valuing Ayurcann Holdings Corp. (AYURF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AYURF?
Before investing in Ayurcann Holdings Corp. (AYURF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data may be subject to change as new information becomes available.